Newsroom
  • July 26 , 2020

    Novel drug delivery particles use neurotransmitters as a 'passport' into the brain

    ​Biomedical engineers at the Tufts University School of Engineering have developed tiny lipid-based nanoparticles that incorporate neurotranmitters to help carry drugs, large molecules, and even gene editing proteins across the blood-brain barrier and into the brain in mice. The innovation, published today in Science Advances, could overcome many of the curr
    Read more
  • July 25 , 2020

    Rapid COVID-19 test detects neutralising antibodies with high specificity and sensitivity

    As the current COVID-19 pandemic continues to adversely impact communities and economies across the world, efficiency in testing for the infection and antibodies is vital. A unique and rapid SARS-CoV-2 surrogate virus neutralization test (sVNT), developed in Singapore, may be the much-needed boost to current COVID-19 investigations to determine infection rat
    Read more
  • July 24 , 2020

    Google AI outperforms general pathologists at validating Gleason grading of prostate cancer biopsies

    A team of researchers from Google Health, working with others from institutions across the U.S. and Canada has found that a Google AI system was able to outperform general pathologists when validating Gleason grading of prostate cancer biopsies. In their paper published in JAMA Oncology, the group describes two major experiments they conducted that compared
    Read more
  • July 24 , 2020

    New study explains how the Warsaw Ghetto beat typhus

    New modeling of typhus infections in the Warsaw Ghetto during WWII reveals how public health interventions eradicated the disease.
    Read more
  • July 23 , 2020

    Battle royale: How bacteria fight antibiotics and up the ante in chemical warfare

    Inadequate development of new antibiotics and rising rates of resistance by bacteria to existing antimicrobials are dual forces pushing the world ever closer to a post-antibiotic era.
    Read more
  • July 23 , 2020

    Lung ultrasound shows duration, severity of coronavirus disease

    According to an open-access article published in ARRS' American Journal of Roentgenology (AJR), lung ultrasound (US) was highly sensitive for detecting abnormalities in patients with coronavirus disease (COVID-19), with B-lines, a thickened pleural line, and pulmonary consolidation the most commonly observed features.
    Read more
  • July 22 , 2020

    Malaria breakthrough set to change vaccine design

    Researchers from the Australian National University (ANU) have discovered a vital clue as to why malaria vaccines keep failing, which could potentially change how vaccines for the deadly disease and others are made.
    Read more
  • July 22 , 2020

    Researchers track down metabolic enzyme that protects against inflammation

    Scrape your knee, and you'll see some red puffiness appear around the injury. This is inflammation, and it is driven by the immune system.
    Read more
  • July 21 , 2020

    Non-invasive blood test can detect cancer four years before conventional diagnosis methods

    An international team of researchers has developed a non-invasive blood test that can detect whether an individual has one of five common types of cancers, four years before the condition can be diagnosed with current methods. The test detects stomach, esophageal, colorectal, lung and liver cancer.
    Read more
  • July 21 , 2020

    Levothyroxine doesn't improve cardiac function for heart attack patients

    Research reveals that treatment of heart attack patients for a common condition, underactive thyroid, with levothyroxine does not improve heart muscle function, so is unlikely to be of benefit.
    Read more
  • July 20 , 2020

    Scientists identify a new drug target for dry age-related macular degeneration

    Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that the blood protein vitronectin is a promising drug target for dry age-related macular degeneration (AMD), a leading cause of vision loss in Americans 60 years of age and older. The study, published in the Proceedings of the National Academy of Sciences (PNAS), also holds implicat
    Read more
  • July 20 , 2020

    Experimental drug reduces replication of zika virus and prevents microcephaly in mice

    An international group of researchers have discovered that inhibiting AHR (aryl hydrocarbon receptor)—a protein with roles in regulating immunity, stem cell maintenance and cellular differentiation—enables the immune system to combat replication of zika virus in the organism far more effectively. In experiments performed at the University of São Paulo's Biom
    Read more
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
If you would like to get in touch with us, please click here. Contact us